Cresco Labs Inc. (CSE:CL)
Canada · Delayed Price · Currency is CAD | Market Cap | 307.90M -45.4% |
| Revenue (ttm) | 924.67M -5.0% |
| Net Income | -143.31M |
| EPS | -0.40 |
| Shares Out | 370.96M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 25,833 |
| Open | 0.8600 |
| Previous Close | 0.8700 |
| Day's Range | 0.8300 - 0.8600 |
| 52-Week Range | 0.8100 - 3.1200 |
| Beta | 1.81 |
| Analysts | Strong Buy |
| Price Target | 2.53 (+205.06%) |
| Earnings Date | Nov 6, 2026 |
About Cresco Labs
Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes, gummies, and pre-rolls under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand. The company ... [Read more]
Financial Performance
In 2025, Cresco Labs's revenue was $655.85 million, a decrease of -9.46% compared to the previous year's $724.34 million. Losses were -$135.41 million, 81.9% more than in 2024.
Financial numbers in USD Financial StatementsAnalyst Summary
According to 6 analysts, the average rating for CL stock is "Strong Buy." The 12-month stock price target is $2.53, which is an increase of 205.06% from the latest price.
News
Cresco Labs Celebrates Sunnyside Prestonsburg Grand Opening, Marking Major Milestone for Kentucky Medical Cannabis
CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), today announced the grand opening of Sunnyside Prestonsburg in Kentucky, the Company's ...
Cannabis Stocks in 2027: New Markets, Reform And Investment Risks
Marijuana stocks to watch in 2027 may be shaped by a combination of state launches, federal rulemaking, and changing competition between licensed cannabis and intoxicating hemp products. That calendar...
Cresco Labs to Report Third Quarter 2026 Financial Results on November 6, 2026
CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or the “Company”), the industry leader in branded cannabis products with a portfolio of America's most popular br...
Marijuana Stocks Expand Beyond Traditional Cannabis Companies
Marijuana stocks could soon see a big jump in overall momentum in the near future. Most of this is based on the growth and expansion of certain public companies. In 2026, we are soon to see the offici...
Cresco Labs Announces Filing of Supplement to Management Information Circular for Annual General and Special Meeting
CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) ("Cresco Labs" or the "Company") today announced that it has filed a supplement (the "Supplement") to its management inform...
3 Cannabis Stocks to Watch Heading Out of September
The marijuana industry is entering another important period for investors as September 2026 gets underway. Cannabis stocks have experienced significant volatility over the past several years. However,...
Cresco Labs Announces Filing of Management Information Circular for Annual General and Special Meeting
CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) ("Cresco Labs" or the "Company") today announced that it has filed its Management Information Circular (the "Circular") a...
Cresco Labs Appoints Edward Tilly to Board of Directors
CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America's most pop...
Cannabis Stocks And Rescheduling: What Investors Should Watch In 2026
More than ever, federal cannabis reform is gaining momentum. With all the progress that has evolved since mid-2018, the future holds untapped potential. But the big issue remains: there is no true fed...
Cresco Labs acquires nine Pennsylvania dispensaries for $50M
Cresco Labs (CRLBF) announced the closing of its acquisition of 100% of the outstanding equity interests in PharmaCann Penn for an aggregate consideration of $50M. The Transaction consists of nine…
Cresco Labs Acquires Nine Pennsylvania Dispensaries in Accretive Transaction to Strengthen Market Leadership
CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”) today announced the closing of its acquisition of 100% of the outstanding equity interes...
These 3 Top Marijuana Stocks Could Be Top Gainers In The Sector
The cannabis industry is once again going through another transitional period. With new laws set to take effect in the US in mid-December, things could ramp up for marijuana stocks. The reason for thi...
3 Marijuana Stocks For Investors To Consider
What will help marijuana stock investors trade more, even in the midst of laws changing in the USA? It is no secret that nothing has moved pot stocks more than news of global reform or regulatory matt...
Cresco Labs price target lowered to C$2.50 from C$3.25 at Alliance Global
Alliance Global analyst Aaron Grey lowered the firm’s price target on Cresco Labs (CRLBF) to C$2.50 from C$3.25 and keeps a Buy rating on the shares. The firm noted that…
Cresco Labs Earnings Call Transcript: Q2 2026
Q2 saw 15% sequential revenue growth to $173M, with strong margin expansion and $15M in operating cash flow. Strategic M&A and disciplined execution drove gains in core markets, while federal rescheduling is expected to further improve industry economics.
Cresco Labs Report: Q2 2026
Cresco Labs published a report on August 6, 2026 containing material business information for investors and shareholders.
Cresco Labs MD&A: Q2 2026
Cresco Labs filed a regulatory document on August 6, 2026 disclosing important business information.
Cresco Labs Earnings release: Q2 2026
Cresco Labs released its Q2 2026 earnings on August 6, 2026, summarizing the period's financial results.
Cresco Labs Slides: Q2 2026
Cresco Labs has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 6, 2026.
Cresco Labs Reports Second Quarter 2026 Financial Results; Delivers $173 Million in Revenue and $40 Million in Adjusted EBITDA
CHICAGO--(BUSINESS WIRE)--Cresco Labs Reports Second Quarter 2026 Financial Results; Delivers $173 Million in Revenue and $40 Million in Adjusted EBITDA.
2 Marijuana Stocks To Watch For Stronger Trading This Week
The path for legal cannabis has been anything but an easy road. There have been many setbacks, failures, and uphill battles that still plague operators. Nevertheless, just like the plant, the industry...
3 Marijuana Stocks For Investors To Buy And Hold Today
The cannabis industry is changing with the new rescheduling of cannabis to a Class 3 substance. For marijuana stock investors, it has been more about preparation, with some mild market action. The pre...
Cresco Labs to Report Second Quarter 2026 Financial Results on August 6, 2026
CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America's most popular brands...
Looking for Cannabis Growth? Watch These 3 Marijuana Stocks in July 2026
The cannabis industry continues evolving as operators focus on profitability, stronger balance sheets, and strategic expansion. At the same time, federal cannabis reform discussions have improved inve...
Top Cannabis Companies Building Momentum in June 2026
The cannabis industry continues to evolve across the United States. Several operators are expanding their retail footprints while improving profitability. At the same time, investors are watching for ...